Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection

Hadi Ghasemi,Seyed Habibollah Mousavibahar,Mohammad Hashemnia,Jamshid Karimi,Iraj Khodadadi,Fatemeh Mirzaei,Heidar Tavilani

DOI: https://doi.org/10.1111/nyas.14358

IF: 6.499

2020-05-19

Annals of the New York Academy of Sciences

Abstract:<p>Changes in the cellular microenvironment play a critical role in the development of bladder cancer (BC). Yes‐associated protein (YAP), a central mediator of the Hippo pathway, functions as a nuclear sensor of mechanotransduction that can be induced by stiffness of the extracellular matrix (ECM), including stiffness resulting from surgical manipulations. We aimed to clarify the possible association between surgically‐related ECM stiffness and YAP activation in BC patients. We compared 30 bladder cancer tissues with grade II (<i>n </i> = 15 recurrent and <i>n </i> = 15 newly diagnosed) with 30 adjacent healthy tissues. Atomic force microscopy showed that patients with recurrent BC had stiffer ECM than newly diagnosed patients (<i>P &lt; </i> 0.05). Gene expression profiles showed that β1 integrin (<i>ITGB1 </i>), focal adhesion kinase (<i>FAK </i>), <i>CDC42 </i>, and <i>YAP </i> were upregulated in cancerous tissues (<i>P &lt; </i> 0.05); additionally, β1 integrin activation was confirmed using a specific antibody. Nuclear localization of YAP was higher in recurrent cancerous tissues compared with newly diagnosed and it was positively associated with higher stiffness (<i>P &lt; </i> 0.05). Our results suggest that postsurgery‐induced ECM stiffness can influence integrin–FAK–YAP activity and thereby YAP trafficking to the nucleus where it contributes to BC progression and relapse.</p>

multidisciplinary sciences